Final answer:
The presence of a chiral center in thalidomide is the structural characteristic that accounts for its dual functionality as a sedative and a teratogen.
Step-by-step explanation:
The structural characteristic of thalidomide that accounts for its dual functionality as a sedative and a teratogen is the presence of a chiral center. A chiral center is an asymmetric carbon atom that gives rise to different enantiomers or mirror-image isomers. Thalidomide has a chiral center, which means it can exist as two different enantiomers: the S-isomer and the R-isomer. The S-isomer is the teratogenic form, responsible for the birth defects associated with thalidomide exposure during pregnancy.